Focus on invasive mucormycosis in paediatric haematology oncology patients: A series of 11 cases

Mycoses

Volumn 56, Issue 3, 2013, Pages 236-240

  Phulpin Weibel, Aurélie ^a   Rivier, Alexandre ^a   Leblanc, Thierry ^b   Bertrand, Yves ^c   Chastagner, Pascal ^a  

^a CHU NANCY BRABOIS   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Cancer; Children; Mucormycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; VORICONAZOLE;

ABSIDIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CUNNINGHAMELLA BERTHOLLETIAE; DEBRIDEMENT; DISEASE PREDISPOSITION; FEMALE; FRANCE; HEMATOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; MALE; MUCOR; MUCORMYCOSIS; MULTICENTER STUDY; NONHUMAN; ONCOLOGY; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHIZOMUCOR PUSILLUS; RHIZOPUS ORYZAE; RISK FACTOR; SCHOOL CHILD; SYSTEMIC MYCOSIS;

ADOLESCENT; AMPHOTERICIN B; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID, ACUTE; LUNG DISEASES, FUNGAL; MALE; MUCOR; MUCORMYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

ABSIDIA CORYMBIFERA; MUCOR;

EID: 84876300062     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12010     Document Type: Article

References (20)

1. Hibbett DS, Binder M, Bischoff JF et al. A higher-level phylogenetic classification of the Fungi. Mycol Res 2007; 111(Pt 5): 509-47.
2. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-53.
3. Skiada A, Pagano L, Groll A et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17: 1859-67.
4. Pagano L, Offidani M, Fianchi L et al. Mucormycosis in hematologic patients. Haematologica. 2004; 89: 207-14.
5. Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol 2009; 31: 911-9.
6. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
7. Zaoutis TE, Roilides E, Chiou CC et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J 2007; 26: 723-7.
8. Dabritz J, Attarbaschi A, Tintelnot K et al. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases. Mycoses 2011; 54: e785-8.
9. Leithauser M, Kahl C, Aepinus C et al. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation. Transpl Infect Dis 2010; 12: 251-7.
10. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?Clin Microbiol Infect 2009; 15(Suppl. 5): 93-7.
11. Wingard JR, Carter SL, Walsh TJ et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010; 116: 5111-8.
12. Kontoyiannis DP, Lewis RE. How i treat mucormycosis. Blood 2011; 118: 1216-24.
13. Spellberg B, Edwards J, Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556-69.
14. Tarrand JJ, Lichterfeld M, Warraich I et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003; 119: 854-8.
15. Landlinger C, Preuner S, Baskova L et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia 2010; 24: 2032-8.
16. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743-51.
17. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52.
18. Reed C, Bryant R, Ibrahim AS et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008; 47: 364-71.
19. Spellberg B, Ibrahim AS, Chin-Hong PV et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67: 715-22.
20. Symeonidis AS. The role of iron and iron chelators in zygomycosis. Clin Microbiol Infect 2009; 15(Suppl. 5): 26-32.